"New scientific studies show that NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin," said Craig T. January, MD, PhD, FACC, co-chair of the focused update.
Further, the decision to use an anticoagulant should not be influenced by whether the AFib is paroxysmal, persistent or permanent."
[
www.acc.org]